This is an excellent share, thanks for this. I think the commentary is spot on - sentiment is at extreme lows, funding risk is at extreme heights, despondency seems to have set in across global markets, and equity markets are risk-off. For unprofitable junior explorers, and even early stage miners, this has led to a brutal sell-off.
I also agree completely that the ideal time to buy is when there is blood on the streets, for quality companies with strong prospects and a strong balance sheet. Nova sold Snow Lake shares at a perfect time, bolstering our balance sheet to ensure drilling could continue with solid momentum, in the lead up to SS2. The underlying business of Nova has (in my opinion) significantly improved in the last two years, and I have taken the opportunity to buy at these levels to take advantage of the depressed SP. It's not without risk, and it requires patience, but I expect our deposit to be valued at many multiples of our current MC in the coming years. I'm happy to wait.
- Forums
- ASX - By Stock
- NVA
- Ann: High Grade Gold Intercepts Continue for Nova at RPM
Ann: High Grade Gold Intercepts Continue for Nova at RPM, page-61
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NVA (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.26M |
Open | High | Low | Value | Volume |
18.5¢ | 19.8¢ | 18.5¢ | $44.45K | 231.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 88199 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 88199 | 0.190 |
4 | 82253 | 0.185 |
5 | 19410 | 0.180 |
2 | 105700 | 0.175 |
4 | 283411 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 20000 | 1 |
0.220 | 42000 | 2 |
0.225 | 43000 | 2 |
0.230 | 74646 | 3 |
0.235 | 20384 | 1 |
Last trade - 14.20pm 12/11/2024 (20 minute delay) ? |
Featured News
NVA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online